ROCKET PHARMACEUTICALS INC shareholders Q3 2023

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 450,000$9,220,5000.54%
TANG CAPITAL MANAGEMENT LLC 150,000$3,073,5000.43%
Avoro Capital Advisors LLC 1,250,000$25,612,5000.40%
Ikarian Capital, LLC 1,500$3,073,5000.37%
Eventide Asset Management 898,000$18,400,0200.33%
GMT CAPITAL CORP 411,200$8,425,4880.32%
HARBOR CAPITAL ADVISORS, INC. 57,317$1,174,4250.25%
Nebula Research & Development LLC 21,435$439,2030.23%
MOODY ALDRICH PARTNERS LLC 58,027$1,188,9730.22%
TORRAY INVESTMENT PARTNERS LLC 60,177$1,233,0270.22%
Hennion & Walsh Asset Management, Inc. 151,074$3,095,5060.20%
VELA Investment Management, LLC 16,079$329,4590.14%
SANDERS MORRIS HARRIS LLC 27,709$541,7410.11%
RICE HALL JAMES & ASSOCIATES, LLC 77,389$1,585,7010.10%
PIER 88 INVESTMENT PARTNERS LLC 18,000$368,8200.09%
BAMCO INC /NY/ 1,108,017$22,703,2680.07%
BOOTHBAY FUND MANAGEMENT, LLC 132,192$2,708,6140.06%
EFG Asset Management (Americas) Corp. 12,840$263,0920.06%
Assenagon Asset Management S.A. 877,140$17,972,5990.06%
Virtus ETF Advisers LLC 4,356$89,2540.05%
External links

This page lists ROCKET PHARMACEUTICALS INC's shareholders in Q3 2023. To view ROCKET PHARMACEUTICALS INC's shareholder history, click here.